Article
Is the IDH Mutation a Good Target for Chondrosarcoma Treatment?
2020-01-11
Abstract excerpt
Abstract Chondrosarcomas are rare cancers of bone that arise from the malignant transformation of cells of chondrocytic lineage. They are known to be resistant to systemic cytotoxic chemotherapy and radiotherapy. The mainstay of management of localised disease is en bloc surgical resection with curative intent. Metastatic chondrosarcoma has a dismal prognosis, and to date, there are no proven effective systemic th...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4faeea96-e829-58c7-9052-5ca6aa6a1a47
- DOI
- 10.1007/s40610-020-00126-z
